|
|
|
Multislice Computed Tomography Has Potential
To Offer Accurate, Safer Method for Detecting Coronary Artery Disease CHICAGO — Multislice computed tomography appears to provide high accuracy for detecting coronary artery disease and may represent a useful complement to conventional coronary angiography, according to a study in the May 25 issue of JAMA. Conventional invasive coronary angiography is currently the diagnostic standard for clinical evaluation of known or suspected coronary artery disease (CAD), according to background information in the article. The risk of adverse events is small, but serious and potentially life-threatening events may occur, including arrhythmia, stroke, coronary artery dissection, and access site bleeding (total complication rate, 1.8 percent; death rate, 0.1 percent). Furthermore, angiography catheterization induces some discomfort and mandates routine follow-up care. Guidelines recommend that conventional invasive diagnostic angiography be restricted to stringent clinical indications. A recently developed procedure that may potentially complement invasive coronary angiography is multislice computed tomography (MSCT), which may achieve a high level of reliability and accuracy in the visualization of the coronary arteries. MSCT is a sophisticated x-ray imaging technique, in which a CT tube and multiple layered detector rows rotate around the patient, taking numerous images of the body in seconds. A computer processes this information into three-dimensional images composing volumetric representations of anatomy. The coronary arteries can be extracted from these images and are presented in arbitrarily oriented sectional cuts. This procedure eliminates much of the risk and discomfort associated with invasive coronary artery catheterization, although it retains the risks inherent in radiation exposure and use of contrast agents. Martin H. K. Hoffmann, M.D., of University Hospital, Ulm, Germany and colleagues assessed the diagnostic accuracy of 16-slice MSCT scanning vs. invasive coronary angiography in a large group of patients with known or suspected CAD. The study, which included 103 patients (average age, 61.5 years), was conducted from November 2003-August 2004. The patients underwent both invasive coronary angiography and MSCT using a scanner with 16 detector rows. The researchers found that compared with invasive coronary angiography for detection of significant lesions (greater than 50 percent stenosis [narrowing]), segment-based sensitivity, specificity, and positive and negative predictive values of MSCT were 95 percent, 98 percent, 87 percent, and 99 percent, respectively. Quantitative comparison of MSCT and invasive coronary angiography showed good correlation, with MSCT systematically measuring greater-percentage stenoses. Per-patient based analysis indicated high discriminative power to identify patients who might be candidates for revascularization. "In conclusion, we found that MSCT shows reasonably high accuracy for detecting significant obstructive CAD when assessed at a patient level. At its current stage of development, it may therefore be used to substantially reduce likelihood of clinically important CAD in patients with suspected disease. The appeal of MSCT compared with conventional coronary angiography is that it is noninvasive, avoiding most catheter-associated risks and discomforts with the exception of exposure to iodinated contrast agents and radiation. With rapidly improving technology, MSCT may well evolve from a useful complement to invasive angiography to a clinically viable alternative," the authors write. (JAMA. 2005;293:2471-2478). Editor's Note: This study was funded by the State Government of Baden-Wuerttemberg, Germany. The computed tomography equipment was partially provided by Philips Medical Systems, Best, the Netherlands, on the basis of a beta-site contract. Source: Journal of the American Medical Association |
Angioplasty.Org Home • PatientCenter
this press release is posted as a reader
service by Angioplasty.org,
an editorially independent informational health
site
which has received unrestricted educational grants from
Medtronic plc,
TCROSS NEWS, Toshiba
America
Medical Systems, Volcano
Corporation, Terumo
Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021
